Search

everythinglearnresearchcommunity

for

Search:↓

Found key genes affecting hair loss, immune response, and skin development; more research needed for better treatments.

Hair loss in twins may be linked to family history of hair loss, high blood pressure, heart disease, and possibly anxiety, but more research is needed.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

Extracts improve hair growth in alopecia.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Knowing about finasteride's sexual side effects increases reported dysfunction.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The Rotterdam Study aims to understand various diseases in older adults.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Finasteride for hair loss can cause long-lasting sexual side effects like low libido and erectile dysfunction.

Women look young for their age due to larger lips, less sun damage, and genes that prevent gray hair and wrinkles.

Current treatments for alopecia show no significant long-term benefits.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.